The scientist’s investigation covers issues in Atrial fibrillation, Internal medicine, Cardiology, Heart failure and Catheter ablation. The concepts of his Atrial fibrillation study are interwoven with issues in Stroke, Randomized controlled trial, Heart disease and Intensive care medicine. His research integrates issues of Endocrinology and Surgery in his study of Internal medicine.
In the subject of general Cardiology, his work in Electrocardiography is often linked to In patient, thereby combining diverse domains of study. He has included themes like Oxidative stress, Cardiotoxicity, Chemotherapy, Bioinformatics and Heart rate in his Heart failure study. Harry J.G.M. Crijns combines subjects such as Platelet aggregation inhibitor, Vitamin K antagonist, Cardiac arrhythmia and Atrial flutter with his study of Catheter ablation.
His scientific interests lie mostly in Internal medicine, Cardiology, Atrial fibrillation, Heart failure and Sinus rhythm. His Internal medicine study frequently intersects with other fields, such as Anesthesia. As part of his studies on Cardiology, Harry J.G.M. Crijns frequently links adjacent subjects like Surgery.
His Atrial fibrillation study combines topics from a wide range of disciplines, such as Stroke, Ablation and Intensive care medicine. His Heart failure study incorporates themes from Randomized controlled trial, Quality of life and Hazard ratio. His Cardiac resynchronization therapy research is multidisciplinary, incorporating perspectives in QRS complex and Left bundle branch block.
Harry J.G.M. Crijns mainly focuses on Internal medicine, Atrial fibrillation, Cardiology, Heart failure and In patient. His studies examine the connections between Internal medicine and genetics, as well as such issues in Diabetes mellitus, with regards to Heart rate variability. His Atrial fibrillation research includes elements of Stroke, mHealth and Emergency department.
His Stroke research is multidisciplinary, incorporating elements of Off-label use, Intensive care medicine, Dosing, Edoxaban and Cohort. Harry J.G.M. Crijns works mostly in the field of Cardiology, limiting it down to topics relating to Odds ratio and, in certain cases, Logistic regression, as a part of the same area of interest. His Heart failure research incorporates themes from Cardiac sarcoidosis, Risk stratification, High morbidity, Risk factor and Comorbidity.
His primary areas of investigation include Atrial fibrillation, Internal medicine, Cardiology, Heart failure and Stroke. His Atrial fibrillation research includes themes of mHealth and Randomized controlled trial. His work carried out in the field of Randomized controlled trial brings together such families of science as Apixaban and Clinical trial.
His work in the fields of Internal medicine, such as Heart rate variability, overlaps with other areas such as Research design. The Cardiology study combines topics in areas such as Odds ratio and Prediabetes. The various areas that Harry J.G.M. Crijns examines in his Stroke study include Coronary artery disease, Intensive care medicine, Thrombosis, Risk factor and Comorbidity.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.
Gregory Y. H. Lip;Robby Nieuwlaat;Ron Pisters;Deirdre A. Lane.
Chest (2010)
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.
Ron Pisters;Deirdre A. Lane;Robby Nieuwlaat;Cees B. de Vos.
Chest (2010)
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
Hugh Calkins;Karl Heinz Kuck;Riccardo Cappato;Josep Brugada.
Europace (2012)
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
Hugh Calkins;Karl Heinz Kuck;Riccardo Cappato;Josep Brugada.
Journal of Interventional Cardiac Electrophysiology (2012)
HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation
Hugh Calkins;Josep Brugada;Douglas L. Packer;Ricardo Cappato.
Europace (2008)
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Yanti Octavia;Carlo G. Tocchetti;Kathleen L. Gabrielson;Stefan Janssens.
Journal of Molecular and Cellular Cardiology (2012)
Atrial fibrillation management: a prospective survey in ESC Member Countries The Euro Heart Survey on Atrial Fibrillation
Robby Nieuwlaat;Alessandro Capucci;A John Camm;S Bertil Olsson.
European Heart Journal (2005)
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Valentin Fuster;Lars E. Rydén;Davis S. Cannom;Harry J. Crijns.
Circulation (2011)
Increased Mortality after Dronedarone Therapy for Severe Heart Failure
Lars Køber;Christian Torp-Pedersen;John J.V. McMurray;Ole Gøtzsche.
The New England Journal of Medicine (2008)
Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction.
Umesh C. Sharma;Saraswati Pokharel;Thomas J. van Brakel;Jop H. van Berlo.
Circulation (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University Medical Center Groningen
University of Liverpool
University of Birmingham
St George's, University of London
Maastricht University
University of Modena and Reggio Emilia
Maastricht University
University of Liverpool
University Medical Center Groningen
University of Amsterdam
Virginia Tech
University of Minnesota
Spanish National Research Council
University of Murcia
Boyce Thompson Institute
University of Natural Resources and Life Sciences
Northeastern University
Yunnan University
University of British Columbia
University of Rennes
École Normale Supérieure
Association for Computational Linguistics
University of Haifa
Colorado State University
University of Cologne
Mayo Clinic